As billionaires race to fund anti-aging projects, a much-discussed trial goes overlooked
Metformin, a diabetes drug, shows promise in preventing aging-related diseases. Nir Barzilai's TAME Trial aims to prove this, facing FDA and funding hurdles. Despite interest, securing the $30-50M needed remains challenging, with hopes pinned on new philanthropists and organizations like Hevolution.
Reference News
As billionaires race to fund anti-aging projects, a much-discussed trial goes overlooked
Metformin, a diabetes drug, shows promise in preventing aging-related diseases. Nir Barzilai's TAME Trial aims to prove this, facing FDA and funding hurdles. Despite interest, securing the $30-50M needed remains challenging, with hopes pinned on new philanthropists and organizations like Hevolution.